Updated results from DESTINY-breast01, a phase 2 trial of trastuzumab deruxtecan (T-DXd) in HER2 positive metastatic breast cancer Meeting Abstract
| Authors: | Modi, S.; Saura, C.; Yamashita, T.; Park, Y. H.; Kim, S. B.; Tamura, K.; Andre, F.; Iwata, H.; Ito, Y.; Tsurutani, J.; Sohn, J.; Denduluri, N.; Perrin, C.; Aogi, K.; Tokunaga, E.; Im, S. A.; Lee, K. S.; Hurvitz, S. A.; Cortes, J.; Lee, C.; Liu, Y.; Zhang, L.; Shahidi, J.; Yver, A.; Baselga, J.; Krop, I. E. |
| Abstract Title: | Updated results from DESTINY-breast01, a phase 2 trial of trastuzumab deruxtecan (T-DXd) in HER2 positive metastatic breast cancer |
| Meeting Title: | 43rd Annual San Antonio Breast Cancer Symposium (2020 SABCS) |
| Journal Title: | Cancer Research |
| Volume: | 81 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2020 Dec 8-11 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2021-02-01 |
| Language: | English |
| ACCESSION: | WOS:000618737700196 |
| PROVIDER: | wos |
| DOI: | 10.1158/1538-7445.SABCS20-PD3-06 |
| Notes: | Meeting Abstract: PD3-06 -- This symposium was held virtually due to COVID-19 -- Source: Wos |
